Aquila Part Prod Com SA
XBSE:AQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aquila Part Prod Com SA
XBSE:AQ
|
RO |
|
A
|
Aldeyra Therapeutics Inc
SWB:137
|
US |
|
A
|
Adaptive Biotechnologies Corp
DUS:1HM
|
US |
|
B
|
BAWAG Group AG
F:0B2
|
AT |
|
Sansan Inc
OTC:SNSNF
|
JP |
|
B
|
Beowulf Mining PLC
SWB:B4E
|
UK |
|
B
|
BAWAG Group AG
VSE:BG
|
AT |
|
L
|
Land Securities Group PLC
F:LSU2
|
UK |
|
True North Copper Ltd
ASX:TNC
|
AU |
|
AVITA Medical Inc
F:51KB
|
US |
Wall St Price Targets
AQ Price Targets Summary
Aquila Part Prod Com SA
According to Wall Street analysts, the average 1-year price target for AQ is 1.62 RON with a low forecast of 1.44 RON and a high forecast of 1.79 RON.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AQ's stock price target?
Price Target
1.62
RON
According to Wall Street analysts, the average 1-year price target for AQ is 1.62 RON with a low forecast of 1.44 RON and a high forecast of 1.79 RON.